552
Views
0
CrossRef citations to date
0
Altmetric
Letters

Efficacy of tocilizumab combined with glucocorticoid in the treatment of Takayasu arteritis in infants

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 439-440 | Received 07 Mar 2023, Accepted 02 May 2023, Published online: 08 Jun 2023

References

  • Clemente G, Silva CA, Sacchetti SB, Ferriani V, Oliveira SK, Sztajnbok F, et al. Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases. Rheumatol Int 2018;38:1089–94.
  • Kierzkowska B, Lipinska J, Baranska D, Niewiadomska-Jarosik K, Biernacka-Zielinska M, Stanczyk J, et al. Takayasu’s arteritis mimicking Kawasaki disease in 7-month-old infant, successfully treated with glucocorticosteroids and intravenous immunoglobulins. Rheumatol Int 2012;32:3655–9.
  • Mathew AJ, Goel R, Kumar S, Danda D. Childhood-onset Takayasu arteritis: an update. Int J Rheum Dis 2016;19:116–26.
  • Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, et al. A randomized, double-blind trial of Abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 2017;69:846–53.
  • Henes JC, Mueller M, Pfannenberg C, Kanz L, Kotter I. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol 2011;29:S43–48.
  • Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol 2003;30:1793–8.